Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. حسب Mohammad Bakhtiari (11838264)

Effects of BM-MSCs on ROS generation in DCS rats. حسب Chen Lu (135200)

الموضوعات:

Pretreatment of BM-MSCs attenuates DCS induced lung inflammation. حسب Chen Lu (135200)

الموضوعات:

Isotype control overlays. حسب Chen Lu (135200)

الموضوعات:

Original uncropped blot. حسب Chen Lu (135200)

الموضوعات:

Characterization of BM-MSC. حسب Chen Lu (135200)

الموضوعات:

Pretreatment of BM-MSCs improves the survival rate and incidence of DCS. حسب Chen Lu (135200)

الموضوعات:

Utilization of anticoagulants at eight hospitals from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

Identification of BM-MSCs. حسب Chen Lu (135200)

الموضوعات:

Effect of BM-MSCs in improving DCS induced lung injury. حسب Chen Lu (135200)

الموضوعات:

Inpatient utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

Indications for warfarin prescription in outpatients and inpatients in 2023. حسب Wei Luo (80175)

الموضوعات:

Outpatient utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

Effects of BM-MSCs on different types of lung cell death in different group. حسب Chen Lu (135200)

الموضوعات:

DDC for four anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

A schematic representation of how BM-MSCs reduce inflammation, oxidative stress, and cell death to alleviate decompression induced acute lung injury. حسب Chen Lu (135200)

الموضوعات:

Raw Data. حسب Chen Lu (135200)

الموضوعات:

Utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

The expenditure on anticoagulants in the period of 2019-2023(million CNY). حسب Wei Luo (80175)

الموضوعات:

Mice subjected to chronic stress and provided with HRW exhibited a significant reduction in oxidative stress levels. حسب Qi He (384033)